NCT02834390 2025-03-05Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)Daiichi SankyoPhase 1 Completed7 enrolled 16 charts
NCT02393859 2024-05-29Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)AmgenPhase 3 Completed111 enrolled 23 charts 1 FDA